Fts3-01-04: final efficacy, safety and biomarker results of the phase 2b/3 randomized, double-blinded, placebo-controlled early trial of atabecestat in preclinical alzheimer's disease
Alzheimer's & Dementia（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要